35 Years of Annals of Oncology
To mark the 35th anniversary of Annals of Oncology, this dedicated webpage offers exclusive content, including interviews with Editors-in-Chief, an in-depth article, and three key infographics.
Annals of Oncology
About Annals of Oncology
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
A multidisciplinary journal publishing articles addressing medical oncology in particular, but also surgery, radiotherapy, paediatric oncology, basic research and the comprehensive management of patients with malignant diseases.
ESMO Members
ESMO Members’ access to Annals of Oncology has never been easier.
Start your journey towards a wealth of information about innovative cancer treatments and translational work related to oncology and precision medicine. Watch the ESMO Members’ access video tutorial and get the most from Annals Of Oncology online version
Current Issue on Annals of Oncology
To access this content, you need to be a ESMO member, please login
- A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma
- Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2+ early breast cancer (EBC)
- Correlation Between Progression-Free and Overall Survival in Patients with Hodgkin Lymphoma: A Comprehensive Analysis of Individual Patient Data from Randomized GHSG Trials
- Avelumab + axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase 3 JAVELIN Renal 101 trial
- Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy
- Response Letter to the Editor